A multiple nanoemulsion based on coenzyme Q10, and a preparation method and application thereof

By combining coenzyme Q10 with water-soluble active substances through multiple nanoemulsion technology, a stable W/O/W nanoemulsion is formed, which solves the problems of low absorption and utilization rate and poor stability of coenzyme Q10, realizes efficient drug deposition and synergistic effect, and improves the convenience and efficacy for users.

CN121312809BActive Publication Date: 2026-11-10INSTITUTE OF ENVIRONMENT AND SUSTAINABLE DEVELOPMENT IN AGRICULTURE CAAS
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202511596400.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2025-11-04
Publication Date
2026-11-10
Estimated Expiration
2045-11-04

AI Technical Summary

Technical Problem

Conventional coenzyme Q10 formulations suffer from low absorption and utilization rates, poor stability, and difficulty in synergistic use with water-soluble active substances, affecting their effectiveness, especially for users who have difficulty swallowing, such as children and the elderly.

Method used

Using multi-layer nanoemulsion technology, coenzyme Q10 is compounded with water-soluble active substances and encapsulated in a multi-layer structure to form a W/O/W type nanoemulsion. By utilizing the small size effect and surface effect of nanoparticles, efficient drug deposition and absorption conduction can be achieved.

Benefits of technology

It improves the bioavailability and stability of coenzyme Q10, enhances its synergistic effect with water-soluble active substances, improves user convenience and efficacy, achieves sustained and targeted drug release, and increases drug loading and encapsulation efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121312809B_ABST
    Figure CN121312809B_ABST
Patent Text Reader

Abstract

The application discloses a multiple nano-emulsion based on coenzyme Q10 and a preparation method and application thereof.The multiple nano-emulsion comprises an inner water phase, an oil phase and an outer water phase in percentage by mass, wherein the inner water phase comprises 0.5-2% of water-soluble active substances and 10-20% of deionized water; the oil phase comprises 0.1-10% of coenzyme Q10, 0.5-5% of amphiphilic emulsifiers, 0.05-0.2% of antioxidants and 20-50% of mixed oils; and the outer water phase comprises 0.5-2% of hydrophilic emulsifiers and 30-70% of deionized water.The application effectively solves the problems of poor water solubility and low effective utilization of coenzyme Q10, improves the defects of conventional tablets and granules of coenzyme Q10, improves the convenience and use effect of users, realizes the mixed use and layered embedding of coenzyme Q10 and water-soluble nutrients, improves the synergistic use effect, and provides the possibility for efficient production and application of coenzyme Q10.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of emulsion technology, and in particular to a multi-nanoemulsion based on coenzyme Q10, its preparation method, and its application. Background Technology

[0002] Coenzyme Q10, also known as ubiquinone, is a benzoquinone fat-soluble compound with a structure similar to vitamin K. It is a fat-soluble substance, poorly soluble in water, and has low bioavailability when administered orally. It is a breakthrough nutrient that helps fight heart disease, cancer, aging, and other ailments. Its basic function is to promote the body's energy metabolism, and it also protects the heart, lowers blood pressure, and enhances immunity. Exogenous coenzyme Q10 has a variety of pharmacological effects, such as antioxidant activity, free radical scavenging, membrane stabilization, anti-shock effects, immune enhancement, and effects on the respiratory system.

[0003] In the existing technology, the conventional formulation of coenzyme Q10 is often in the form of tablets or granules. However, the process requires the addition of a large number of excipients such as fillers, binders, disintegrants and lubricants, which increases the metabolic burden on the user's digestive system, resulting in low absorption and utilization. At the same time, it causes inconvenience to users who have difficulty swallowing, such as children and the elderly, and affects the effectiveness of use.

[0004] Furthermore, as a fat-soluble active substance, Coenzyme Q10's hydrophobic properties result in low bioavailability. Meanwhile, current research indicates that coenzyme Q10 and water-soluble active substances, when taken together, produce a synergistic effect, exerting their antioxidant, cardiovascular protective, and energy metabolism functions. However, existing technologies, such as CN101966171B, which discloses a water-soluble reduced coenzyme Q10 composition and its preparation method, simply mix coenzyme Q10 and the water-soluble active substance, leading to poor stability of the finished product and problems such as easy separation and low bioavailability. Therefore, there is an urgent need for a coenzyme Q10-based multi-nanoemulsion, its preparation method, and its application to enhance the synergistic effect and solve the above-mentioned technical problems. Summary of the Invention

[0005] The purpose of this invention is to provide a multi-nanoemulsion based on coenzyme Q10, its preparation method, and its application. This invention can effectively solve the problems of poor water solubility and low utilization of coenzyme Q10, improve the defects of conventional coenzyme Q10 tablets and granules, enhance user convenience and efficacy, realize the combined use and layered encapsulation of coenzyme Q10 with water-soluble nutrients, improve their synergistic effect, and provide the possibility for the efficient production and application of coenzyme Q10, thus solving the problems existing in the prior art.

[0006] A coenzyme Q10-based multiple nanoemulsion, comprising, by mass percentage, The internal aqueous phase comprises 0.5% to 2% water-soluble active substances and 10% to 20% deionized water; The oil phase comprises 0.1% to 10% coenzyme Q10, 0.5% to 5% amphiphilic emulsifier, 0.05% to 0.2% antioxidant, and 20% to 50% mixed oils; The external aqueous phase comprises 0.5% to 2% hydrophilic emulsifier and 30% to 70% deionized water.

[0007] Preferably, the water-soluble active substances include one or more of the following: B vitamins, vitamin C, glucosamine, curcumin, L-carnitine, apple polyphenols, tremella polysaccharides, brown algae polysaccharides, astragalus polysaccharides, ginseng polysaccharides, ganoderma lucidum polysaccharides, kudzu root flavonoids, pomegranate extract, broccoli extract, perilla extract, water-soluble ginsenosides, active folic acid, anthocyanins, resveratrol, α-lipoic acid, carnosine, and taurine.

[0008] Preferably, the amphiphilic emulsifier includes one or more of glyceryl monostearate, glyceryl monooleate, decaglyceryl decastearate, polyglyceryl polyricinoleate, Span 60, Span 80, hydroxylated lecithin, and sucrose distearate.

[0009] Preferably, the antioxidant includes one or more of ascorbyl palmitate, dilaurate thiodipropionate, butylated hydroxyanisole, and butylated hydroxytoluene.

[0010] Preferably, the mixed oil consists of edible oils and oil-soluble natural extracts.

[0011] Preferably, the edible oils include one or more of rapeseed oil, coconut oil, triglycerides, diglyceride oil, fish oil, algal oil, mixed biophenols, and α-tocopherol acetate.

[0012] Preferably, the oil-soluble natural extract includes one or more of squalene, astaxanthin, grape seed oil, and Ganoderma lucidum spore oil.

[0013] Preferably, the hydrophilic emulsifier includes one or more of Tween 60, Tween 80, sucrose monostearate, sucrose monolaurate, polyglycerol monostearate, polyglycerol monooleate, lactic acid fatty acid glyceride, citrate fatty acid glyceride, and succinate fatty acid glyceride.

[0014] A method for preparing the coenzyme Q10-based multiple nanoemulsion, characterized by comprising the following steps: S1, the coenzyme Q10, amphiphilic emulsifier, antioxidant, and mixed oil are mixed evenly under stirring conditions of 800-1200 rpm / min to form an oil phase; S2, the water-soluble active substance and deionized water are mixed evenly under stirring conditions of 300-500 rpm / min to form an inner aqueous phase; S3, the hydrophilic emulsifier and deionized water are mixed evenly under stirring conditions of 300-500 rpm / min to form an external aqueous phase; S4, the internal aqueous phase is added dropwise to the oil phase at a speed of 10-25 ml / min under a rotation speed of 800-1000 rpm / min. After continuous stirring for 5-10 min, a mixture is formed. The mixture is then added to a high-pressure homogenizer at a temperature of 25-35℃ and emulsified and dispersed at a pressure of 150-180 bar for at least 2 cycles, followed by emulsification and dispersion at a pressure of 600-1200 bar for at least 10 cycles. The high-pressure homogenizer needs to be cooled throughout the process to finally obtain a W / O type primary emulsion. S5, under a pressure of 60-80 kPa, the W / O type primary emulsion is pressed into 1 / 3 of the volume of the external aqueous phase through an SPG microporous membrane with a pore size of 0.05 μm-0.15 μm to obtain a primary mixture. The primary mixture is then pressed into the remaining 2 / 3 of the external aqueous phase through the SPG microporous membrane under a pressure of 60-80 kPa. The mixture is collected and stirred for another 20 min to obtain a W / O / W multiple nanoemulsion.

[0015] The coenzyme Q10 multiple nanoemulsion prepared by this invention has an average particle size of 50-200 nm, uniform particle size, and stable product quality.

[0016] The application of the coenzyme Q10-based multiple nanoemulsion in the preparation of health products, nutritional supplements, food, pet food, and cosmetics.

[0017] The present invention discloses the following technical effects: 1. This invention provides a multi-layer nanoemulsion based on coenzyme Q10, its preparation method, and its application. Through composite nanoemulsion preparation technology, coenzyme Q10 and other water-soluble active substances are combined to form a new drug-loaded system. This solves the problems of poor stability, easy separation and precipitation, and low bioavailability caused by simple mixing of coenzyme Q10 and water-soluble nutrients. The multi-layer structure of the multi-layer nanoemulsion can encapsulate coenzyme Q10 and various water-soluble active substances, increasing the drug loading and encapsulation efficiency, achieving sustained or targeted drug release, prolonging the drug's action time, and reducing the frequency of administration. By controlling the process preparation conditions, the composite nanoemulsion utilizes the small size effect and surface effect of nanoparticles to achieve efficient drug deposition and absorption, effectively solving the problems of poor water solubility and low bioavailability of coenzyme Q10.

[0018] 2. The coenzyme Q10 multiple nanoemulsion prepared by this invention is uniform and stable. By multiple encapsulating coenzyme Q10 and water-soluble nutrients, the coenzyme Q10 and water-soluble nutrients can be mixed and used in combination and layered encapsulation. During the release process of the multiple nanoemulsion, firstly, the coenzyme Q10 in the oil phase provides energy to cells in the body and eliminates free radicals, and then the nutrients in the aqueous phase exert the body's repair function, thereby enhancing their synergistic effect.

[0019] 3. The coenzyme Q10 multiple nanoemulsion prepared by this invention has an average particle size of 50-200 nm, uniform particle size, stable product quality, significantly improved particle specific surface area, enhanced contact area between active substances and lesion sites, increased absorption and utilization of nutrients, and improved effective utilization rate of coenzyme Q10.

[0020] 4. The coenzyme Q10 multiple nanoemulsion prepared by this invention improves the defects of conventional coenzyme Q10 tablets and granules, enhances user convenience and efficacy, and has a safe and efficient production process, making it possible for the efficient production and application of coenzyme Q10.

[0021] This multi-layer nanoemulsion not only ensures the stability and bioavailability of coenzyme Q10, but also promotes the absorption and utilization of water-soluble active substances. The process is stable and can be continuously produced, making it suitable for health products, nutritional supplements, food, pet food, cosmetics and other fields. Attached Figure Description

[0022] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.

[0023] Figure 1 : Flowchart of a method for preparing a multi-layer nanoemulsion based on coenzyme Q10 according to the present invention; Figure 2 Morphology of the coenzyme Q10-based multiple nanoemulsion prepared in Example 1 of this invention; Figure 3 Morphology of the coenzyme Q10-based multiple nanoemulsion prepared in Example 2 of this invention; Figure 4 Morphology of the coenzyme Q10-based multiple nanoemulsion prepared in Example 3 of this invention; Figure 5 : Morphology of the coenzyme Q10-based multiple nanoemulsion prepared in Comparative Example 1 of this invention; Figure 6The morphology of the coenzyme Q10-based multiple nanoemulsion prepared in Comparative Example 2 of this invention is shown in the figure. Detailed Implementation

[0024] The technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.

[0025] To make the above-mentioned objects, features and advantages of the present invention more apparent and understandable, the present invention will be further described in detail below with reference to the accompanying drawings and specific embodiments. Example

[0026] A coenzyme Q10-based multiple nanoemulsion and its preparation method, comprising the following steps: (1) First, mix the mixed oil consisting of 0.4g coenzyme Q10, 0.45g glyceryl monostearate, 0.05g butylated hydroxyanisole, 4.5g rapeseed oil and 1.0g Ganoderma lucidum spore oil evenly under stirring at 800rpm / min to form an oil phase; (2) Mix 0.25g of Ganoderma lucidum polysaccharide and 0.75ml of deionized water at 300rpm / min to form an inner aqueous phase, and mix 0.2g of Tween 80 and 12.4ml of deionized water at 300rpm / min to form an outer aqueous phase; (3) The internal aqueous phase is added to the oil phase at a speed of 10 ml / min under a rotation speed of 800 rpm / min. After stirring for 5 min, a mixture is formed. The mixture is added to a high-pressure homogenizer and emulsified and dispersed 3 times at a temperature of 25°C and a pressure of 150 bar, and then emulsified and dispersed 12 times at a pressure of 600 bar. The high-pressure homogenizer needs to be cooled throughout the process to finally obtain the W / O type primary emulsion.

[0027] (4) Take 1 / 3 of the external aqueous phase and press the primary emulsion into the 1 / 3 of the external aqueous phase through a 0.05 μm SPG microporous membrane under a pressure of 60 kPa to obtain a primary mixture. Press the collected primary mixture into the remaining 2 / 3 of the external aqueous phase through a 0.05 μm SPG microporous membrane under a pressure of 60 kPa. After collecting the mixture and stirring for 20 min, a uniform and stable W / O / W multiple nanoemulsion is obtained.

[0028] This invention prepared a 2% coenzyme Q10 / Ganoderma lucidum polysaccharide multiple nanoemulsion, and the transmission electron microscopy characterization results are as follows. Figure 2As shown, the multiple nanoemulsions exhibit a two-layer embedded morphology, with the red-marked area representing the embedded layer, and the particle size is around 70 nm. Example

[0029] A coenzyme Q10-based multiple nanoemulsion and its preparation method, comprising the following steps: (1) First, mix the mixed oil consisting of 1.0g coenzyme Q10, 0.45g Span 80, 0.05g butylated hydroxytoluene, 3.0g rapeseed oil and 0.5g grapeseed oil evenly under stirring conditions of 800rpm / min to form an oil phase; (2) Mix 0.2g of vitamin C and 0.6ml of deionized water at 400rpm / min to form an inner aqueous phase, and mix 0.2g of lactic acid fatty acid glyceride and 14ml of deionized water at 400rpm / min to form an outer aqueous phase; (3) The internal aqueous phase is added dropwise to the oil phase at a speed of 1000 rpm / min and stirred continuously for 10 min. The mixture is then added to a high-pressure homogenizer and emulsified and dispersed 5 times at a pressure of 180 bar and 15 times at a pressure of 1000 bar. The high-pressure homogenizer needs to be cooled throughout the process to finally obtain the W / O type primary emulsion.

[0030] (4) Take 1 / 3 of the volume of the external aqueous phase and press the initial emulsion into the external aqueous phase through a 0.1 μm SPG microporous membrane under a pressure of 80 kPa to obtain a primary mixture. Press the collected primary mixture into the remaining 2 / 3 of the external aqueous phase through a 0.1 μm SPG microporous membrane under a pressure of 80 kPa. Collect the mixture and continue stirring for 20 min. After sterilization, a uniform and stable W / O / W multiple nanoemulsion is obtained.

[0031] This invention prepared a 5% coenzyme Q10 / vitamin C multiple nanoemulsion, and the transmission electron microscopy characterization results are as follows. Figure 3 As shown, the multiple nanoemulsions exhibit a two-layer embedded morphology, with the red-marked area representing the embedded layer, and the particle size is around 120 nm. Example

[0032] A coenzyme Q10-based multiple nanoemulsion and its preparation method, comprising the following steps: (1) First, mix 2.0g coenzyme Q10, 0.5g Span 80, 0.15g hydroxylated lecithin, 0.05g butylated hydroxytoluene, 4.0g olive oil and 0.2g squalene in a mixture of oils and fats under stirring at 1200rpm / min to form an oil phase. (2) Mix 0.2g glucosamine and 0.7ml deionized water at 500rpm / min to form an inner aqueous phase, and mix 0.2g citrate fatty acid glyceride and 12ml deionized water at 500rpm / min to form an outer aqueous phase; (3) The internal aqueous phase is added dropwise to the oil phase at a speed of 1000 rpm / min and stirred continuously for 5 min. The mixture is then added to a high-pressure homogenizer and emulsified and dispersed 5 times at a pressure of 180 bar and 20 times at a pressure of 1200 bar. The high-pressure homogenizer needs to be cooled throughout the process to finally obtain the W / O type primary emulsion.

[0033] (4) Take 1 / 3 of the external aqueous phase and press the primary emulsion into the external aqueous phase through a 0.15 μm SPG microporous membrane under a pressure of 80 kPa to obtain a primary mixture. Press the collected primary mixture into the remaining 2 / 3 of the external aqueous phase through a 0.15 μm SPG microporous membrane under a pressure of 80 kPa. Collect the mixture and continue stirring for 20 min. After sterilization, a uniform and stable W / O / W multiple nanoemulsion is obtained.

[0034] This invention prepared a 10% coenzyme Q10 / curcumin multiple nanoemulsion, and the transmission electron microscopy characterization results are as follows. Figure 4 As shown, the multiple nanoemulsions exhibit a two-layer embedded morphology, with the red-marked area representing the embedded layer, and the particle size is approximately 180 nm.

[0035] Comparative Example 1 A method for preparing a 5% coenzyme Q10 / vitamin C monolayer emulsion is provided, including the following steps: (1) First, mix the mixed oil consisting of 1.0g coenzyme Q10, 0.45g Span 80, 0.05g butylated hydroxytoluene, 3.0g rapeseed oil and 0.5g grapeseed oil evenly under stirring conditions of 800rpm / min to form an oil phase; (2) Mix 0.2g vitamin C, 0.2g lactic acid fatty acid glyceride and 14.6ml deionized water evenly under stirring at 400rpm / min to form an aqueous phase; (3) The oil phase was added dropwise to the aqueous phase at a speed of 1000 rpm / min and stirred continuously for 10 min. After sterilization, the final O / W monolayer emulsion was obtained.

[0036] This invention prepared a 5% coenzyme Q10 / vitamin C monolayer emulsion, and the transmission electron microscopy characterization results are as follows. Figure 5 As shown, the particle size is around 3 μm.

[0037] Comparative Example 2 Comparative Example 2 provides a method for preparing a 5% Coenzyme Q10 emulsion, including the following steps: (1) First, mix the mixed oil consisting of 1.0g coenzyme Q10, 0.45g Span 80, 0.05g butylated hydroxytoluene, 3.0g rapeseed oil and 0.5g grapeseed oil evenly under stirring conditions of 800rpm / min to form an oil phase; (2) Mix 0.2g of lactic acid fatty acid glyceride and 14.8ml of deionized water at 400rpm / min to form an aqueous phase; (3) The oil phase was added dropwise to the aqueous phase at a speed of 1000 rpm / min and stirred continuously for 10 min. After sterilization, the final O / W monolayer emulsion was obtained.

[0038] This invention prepared a 5% coenzyme Q10 monolayer emulsion, and the transmission electron microscopy characterization results are as follows. Figure 6 As shown, the particle size is around 1 μm.

[0039] Stability test The coenzyme Q10 multilayer emulsions prepared in Examples 1-3 and the coenzyme Q10 monolayer emulsions prepared in Comparative Examples 1-2 were placed at a temperature of 40°C and a relative humidity of 75% for 3 months. The coenzyme Q10 content was tested periodically, and the results are shown in Table 1.

[0040] Table 1

[0041] Results and Discussion: Table 1 shows the changes in the content of coenzyme Q10 and other active substances after 3 months of storage in different examples and comparative examples. In Examples 1 to 3, the coenzyme Q10 multiple nanoemulsions all showed excellent storage stability after 3 months of storage under accelerated storage conditions. The loss rates of coenzyme Q10 in Examples 1 to 3 were 0.75%, 2% and 1%, respectively; while the loss rates of coenzyme Q10 in Comparative Examples 1 and 2 were as high as 7% and 8%.

[0042] Bioavailability test Healthy rats were selected and randomly divided into 6 groups. Coenzyme Q10 preparations from Examples 1-3 and Comparative Examples 1-2 were administered to the rats via gavage, with deionized water serving as the control group. The dosage for each group was 10 mg / kg. Blood samples were collected at different time points after administration to determine the concentration of coenzyme Q10 in the blood.

[0043] The results showed that, with deionized water administered by gavage as the control group, the peak concentration of coenzyme Q10 in the blood of rats treated with the multilayer emulsion of the present invention was (550±50) ng / mL, and the time to reach the peak was 2 hours; while the peak concentration of coenzyme Q10 in the blood of rats given with ordinary coenzyme Q10 preparation was (400±40) ng / mL, and the time to reach the peak was 3 hours. The bioavailability of the multilayer emulsion of coenzyme Q10 of the present invention was significantly higher than that of ordinary coenzyme Q10 preparation.

[0044] Antioxidant and cell-protective effects RAW264.7 mouse macrophages were selected, and cultured RAW264.7 cells were seeded into 96-well plates at a density of 1×105 cells / mL, 100 μL per well. After culturing in a 5% CO2 incubator at 37℃ for 24 h, the culture medium was discarded, and fresh culture medium containing H2O2 was added for 2 h. Cell viability was determined by the CCK-8 assay. When the cell viability was around 50%, the cells were considered to be in a state of oxidative stress. The corresponding H2O2 concentration was the optimal concentration for establishing an oxidative stress model. Coenzyme Q10 preparations from Example 2 and Comparative Examples 1-2 were taken, appropriately diluted, and added to drug-containing culture medium to determine their effect on the survival rate of RAW264.7 cells induced by H2O2 oxidative damage. Cell ROS level was measured: cells were cultured in black 96-well plates, and the cell seeding and drug treatment methods were the same as described above. Follow the instructions of the ROS assay kit. After cell culture, discard the supernatant and wash once with PBS. Add 100 μL of serum-free medium containing 10 μmol / L DCFH-DA probe to each well and incubate at 37°C in the dark for 40 min. Wash twice with PBS to thoroughly remove any DCFH-DA that has not entered the cells. Resuspend the cells after washing and measure the fluorescence intensity at a wavelength of 525 nm. Set the fluorescence intensity of the normal group as 100% and calculate the relative fluorescence intensity of the other groups.

[0045] The results showed that at a concentration of 200 μg / mg, the cell viability and antioxidant indicators after treatment in Example 2 were significantly affected compared to the H2O2 model group (P<0.05). Furthermore, the cell protection indicators and intracellular reactive oxygen species (ROS) indicators measured in Example 2 were significantly different compared to Comparative Examples 1 and 2 (P<0.05). Example 2 showed a significant increase in cell viability of 17.80% and a decrease in intracellular ROS levels of 41.53% (VCEAC). In Comparative Examples 1 and 2, cell viability increased by 7.44% and 5.18%, respectively, and ROS levels decreased by 15.53% (VCEAC) and 13.22% (VCEAC), respectively. These results indicate that the coenzyme Q10 multilayer emulsion of the present invention has significant cell protection and antioxidant activity, and the activity is significantly higher (P<0.05) than that of traditional coenzyme preparations.

[0046] Table 2. Results of antioxidant and cytoprotective effects in different embodiments and comparative examples.

[0047] The embodiments described above are merely preferred embodiments of the present invention and are not intended to limit the scope of the present invention. Various modifications and improvements made by those skilled in the art to the technical solutions of the present invention without departing from the spirit of the present invention should fall within the protection scope defined by the claims of the present invention.

Claims

1. A multi-nanoemulsion based on coenzyme Q10, characterized in that, The multiple nanoemulsion has a W / O / W structure with an average particle size of 50–200 nm, and comprises, by mass percentage: The internal aqueous phase is composed of water-soluble active substances and deionized water; the content of the water-soluble active substances is 0.5% to 2%; the water-soluble active substances are one or more of vitamin C, glucosamine, and Ganoderma lucidum polysaccharides. The oil phase comprises 0.1%–10% coenzyme Q10, 0.5%–5% amphiphilic emulsifier, 0.05%–0.2% antioxidant, and 20%–50% mixed oils; the mixed oils consist of edible oils and oil-soluble natural extracts. The external aqueous phase comprises 0.5% to 2% hydrophilic emulsifier and 30% to 70% deionized water; The preparation method of coenzyme Q10-based multiple nanoemulsions includes the following steps: S1, the coenzyme Q10, amphiphilic emulsifier, antioxidant, and mixed oil are mixed evenly in proportion to form an oil phase; S2, the water-soluble active substance and deionized water are mixed evenly to form an inner aqueous phase; S3, the hydrophilic emulsifier and deionized water are mixed evenly to form an external aqueous phase; S4, the internal aqueous phase is added to the oil phase to form a mixture, and the mixture is homogenized under high pressure to finally obtain a W / O type primary emulsion; In step S4, the internal aqueous phase is added dropwise to the oil phase at a speed of 10-25 ml / min under a rotation speed of 800-1000 rpm. After continuous stirring for 5-10 min, a mixture is formed. The mixture is then added to a high-pressure homogenizer at a temperature of 25-35°C. After emulsification and dispersion cycles at 150-180 bar, the mixture is emulsified and dispersed at 600-1200 bar at least 10 times. The high-pressure homogenizer needs to be cooled throughout the process to finally obtain a W / O type primary emulsion. S5, the W / O type primary emulsion is pressed into 1 / 3 of the volume of the external aqueous phase to obtain a primary mixture. The primary mixture is then pressed into the remaining 2 / 3 of the external aqueous phase. The mixture is collected and stirred to obtain a W / O / W multiple nanoemulsion. The average particle size of the prepared W / O / W multiple nanoemulsion is 50-200 nm. In step S5, under a pressure of 60–80 kPa, the W / O type primary emulsion is pressed into 1 / 3 of the volume of the external aqueous phase through an SPG microporous membrane with a pore size of 0.05 μm–0.15 μm to obtain a primary mixture. The primary mixture is then pressed into the remaining 2 / 3 of the external aqueous phase through the SPG microporous membrane under a pressure of 60–80 kPa. The mixture is collected and stirred for another 20 min to obtain a W / O / W multiple nanoemulsion.

2. The multi-nanoemulsion based on coenzyme Q10 according to claim 1, characterized in that, The amphiphilic emulsifier includes one or more of glyceryl monostearate, glyceryl monooleate, decaglyceryl decastearate, polyglyceryl polyricinoleate, Span 60, Span 80, hydroxylated lecithin, and sucrose distearate; the antioxidant includes one or more of ascorbyl palmitate, dilaurate thiodipropionate, butylated hydroxyanisole, and butylated hydroxytoluene.

3. The multi-nanoemulsion based on coenzyme Q10 according to claim 1, characterized in that, The edible oils include one or more of rapeseed oil, coconut oil, medium-chain triglycerides, diglyceride oil, fish oil, algae oil, mixed biophenols, and α-tocopherol acetate; the oil-soluble natural extracts include one or more of squalene, astaxanthin, grape seed oil, and Ganoderma lucidum spore oil.

4. The multi-nanoemulsion based on coenzyme Q10 according to claim 1, characterized in that, The hydrophilic emulsifier includes one or more of Tween 60, Tween 80, sucrose monostearate, sucrose monolaurate, polyglycerol monostearate, polyglycerol monooleate, lactic acid fatty acid glycerides, citrate fatty acid glycerides, and succinate fatty acid glycerides.

5. The method for preparing a coenzyme Q10-based multiple nanoemulsion according to any one of claims 1 to 4, characterized in that, Includes the following steps: S1, the coenzyme Q10, amphiphilic emulsifier, antioxidant, and mixed oil are mixed evenly in proportion to form an oil phase; S2, the water-soluble active substance and deionized water are mixed evenly to form an inner aqueous phase; S3, the hydrophilic emulsifier and deionized water are mixed evenly to form an external aqueous phase; S4, the internal aqueous phase is added to the oil phase to form a mixture, and the mixture is homogenized under high pressure to finally obtain a W / O type primary emulsion; In step S4, the internal aqueous phase is added dropwise to the oil phase at a speed of 10-25 ml / min under a rotation speed of 800-1000 rpm. After continuous stirring for 5-10 min, a mixture is formed. The mixture is then added to a high-pressure homogenizer at a temperature of 25-35°C. After emulsification and dispersion cycles at 150-180 bar, the mixture is emulsified and dispersed at 600-1200 bar at least 10 times. The high-pressure homogenizer needs to be cooled throughout the process to finally obtain a W / O type primary emulsion. S5, the W / O type primary emulsion is pressed into 1 / 3 of the volume of the external aqueous phase to obtain a primary mixture. The primary mixture is then pressed into the remaining 2 / 3 of the external aqueous phase. The mixture is collected and stirred to obtain a W / O / W multiple nanoemulsion. The average particle size of the prepared W / O / W multiple nanoemulsion is 50-200 nm. In step S5, under a pressure of 60–80 kPa, the W / O type primary emulsion is pressed into 1 / 3 of the volume of the external aqueous phase through an SPG microporous membrane with a pore size of 0.05 μm–0.15 μm to obtain a primary mixture. The primary mixture is then pressed into the remaining 2 / 3 of the external aqueous phase through the SPG microporous membrane under a pressure of 60–80 kPa. The mixture is collected and stirred for another 20 min to obtain a W / O / W multiple nanoemulsion.

6. The method for preparing a coenzyme Q10-based multiple nanoemulsion according to claim 5, characterized in that, In step S1, the coenzyme Q10, amphiphilic emulsifier, antioxidant, and mixed oils are mixed evenly under stirring conditions of 800-1200 rpm to form an oil phase. In step S2, the water-soluble active substance and deionized water are mixed evenly under stirring conditions of 300-500 rpm to form an inner aqueous phase; In step S3, the hydrophilic emulsifier and deionized water are mixed evenly under stirring conditions of 500-800 rpm to form an external aqueous phase.

7. The application of the coenzyme Q10-based multiple nanoemulsion prepared by any one of claims 1 to 4 or by any one of claims 5 to 6 in the preparation of food, pet food, and cosmetics.

8. The application of the coenzyme Q10-based multiple nanoemulsion prepared by any one of claims 1 to 4 or by any one of claims 5 to 6 in the preparation of health products and nutritional supplements.

Citation Information

Patent Citations

  • Hydrosoluble reduced enzyme Q10 composition and preparation method thereof

    CN101966171B

  • Coenzyme Q10 and vitamin C composite emulsion and preparation method thereof

    CN117338768A

  • Multilayer composite microemulsion and facial mask

    CN119139174A

  • Stabilized w / O / W emulsion and manufacturing method therefor

    JP2003164754A

  • Cosmetic composition having water in oil in water type multiple emulsion phase comprising a anionic surfactant and manufacturing method thereof

    KR1020130087332A